Better Fecal Live Microbiota Outcomes Linked to Gut Microbio

New PUNCH CD3 analyses show patients who were treated with live fecal microbiota therapy improved their gut health at 8 weeks—which correlated with improved quality-of-life scores.

Related Keywords

Vancouver , British Columbia , Canada , Paul Feuerstadt , Yale University School Of Medicine , Gastroenterology Center , American College Of Gastroenterology , C Difficile Quality Of Life Survey Cdiff , American College , Scientific Meeting , Yale University School , Life Survey , Rebyota , Spreferring , Punch Cd3 , C Difficile , Ccdi , Rcdi , C Diff , Microbiota , Gut , Health ,